EP3360581 - PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING INHIBITOR OF PLRG1 (PLEIOTROPIC REGULATOR 1) AS ACTIVE INGREDIENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.08.2024 Database last updated on 03.09.2024 | |
Former | Examination is in progress Status updated on 20.06.2020 | ||
Former | Request for examination was made Status updated on 13.07.2018 | ||
Former | The international publication has been made Status updated on 18.04.2017 | Most recent event Tooltip | 15.08.2024 | Application deemed to be withdrawn | published on 18.09.2024 [2024/38] | Applicant(s) | For all designated states Korea Institute of Radiological & Medical Sciences 75 Nowon-ro Nowon-gu Seoul 01812 / KR | [2018/33] | Inventor(s) | 01 /
LEE, Kee-Ho 603-403 71 Sirubong-ro Dobong-gu Seoul 01374 / KR | 02 /
KIM, Sungsub 307-1404 448 Expo-ro Yuseong-gu Daejeon 34049 / KR | 03 /
KIM, Yeon-Soo 1111ho 11 Gyeryong-ro 52beon-gil Yuseong-gu Daejeon 34178 / KR | 04 /
PARK, Eun-Ran 103-408 19 Gongneung-ro 46-gil Nowon-gu Seoul 01813 / KR | 05 /
SHIN, Hyun Jin 108-101 10 Cheonho-daero 199-gil Gangdong-gu Seoul 05348 / KR | 06 /
LEE, Eun-Ju 103-701 7 Baekjegobun-ro 18-gil Songpa-gu Seoul 05577 / KR | 07 /
HAM, Yong-Ho 12 Suraksan-ro 6-gil Nowon-gu Seoul 05577 / KR | 08 /
KIM, Sang Bum 107-1202 14 Ichon-ro 87-gil Yongsan-gu Seoul 04424 / KR | 09 /
PARK, Sun-Hoo 1401-1202 537-17 Achasan-ro Gwangjin-gu Seoul 04983 / KR | 10 /
HAN, Chul-Ju B-2503 235 Toegye-ro Jung-gu Seoul 04558 / KR | 11 /
HONG, Sung Hee 101-1402 32 Dobong-ro 180ga-gil Dobong-gu Seoul 01318 / KR | 12 /
KIM, Yang Hyun 303ho 53-46 Dongil-ro 186-gil Nowon-gu Seoul 01843 / KR | 13 /
KIM, Jung Min 502ho 170-2 Galhyeon-ro Eunpyeong-gu Seoul 03410 / KR | 14 /
KIM, Mi Yeun 113-705 165 Buyeong-ro Bupyeong-gu Incheon 21377 / KR | 15 /
KANG, Moonkyoung 106-604 65 Gajeong-ro Yuseong-gu Daejeon 34120 / KR | 16 /
SONG, Eun Yeong 205-502 35 Yongjeong-ro Sangdang-gu Cheongju-si Chungcheongbuk-do 28748 / KR | 17 /
SONG, Jie Young 10, Yeouidong-ro 3-gil Yeongdeungpo-gu Seoul 07324 / KR | [2018/33] | Representative(s) | Gassner, Birgitta, et al REDL Life Science Patent Attorneys Donau-City-Straße 11 1220 Wien / AT | [2018/33] | Application number, filing date | 16853944.3 | 07.10.2016 | [2018/33] | WO2016KR11272 | Priority number, date | KR20150141667 | 08.10.2015 Original published format: KR 20150141667 | [2018/33] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017061828 | Date: | 13.04.2017 | Language: | KO | [2017/15] | Type: | A1 Application with search report | No.: | EP3360581 | Date: | 15.08.2018 | Language: | EN | [2018/33] | Search report(s) | International search report - published on: | KR | 13.04.2017 | (Supplementary) European search report - dispatched on: | EP | 06.05.2019 | Classification | IPC: | C12N15/113, A61K48/00, A61K39/395 | [2022/02] | CPC: |
C12N15/1135 (EP,US);
A61K48/00 (EP,KR,US);
A61K39/395 (EP,KR,US);
A61K39/39558 (KR);
A61P35/00 (EP,US);
C12N15/1138 (EP,US);
G01N33/57496 (US);
C12N2310/11 (EP,US);
C12N2310/14 (EP,US);
|
Former IPC [2019/23] | A61K48/00, A61K39/395, C12N15/113 | ||
Former IPC [2018/33] | A61K48/00, A61K39/395 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/33] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON KREBS MIT INHIBITOR VON PLRG1 (PLEIOTROPER REGULATOR 1) ALS WIRKSTOFF | [2018/33] | English: | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING INHIBITOR OF PLRG1 (PLEIOTROPIC REGULATOR 1) AS ACTIVE INGREDIENT | [2018/33] | French: | COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER UN CANCER COMPRENANT UN INHIBITEUR DE PLRG1 (RÉGULATEUR PLÉIOTROPIQUE 1) COMME PRINCIPE ACTIF | [2018/33] | Entry into regional phase | 08.05.2018 | Translation filed | 08.05.2018 | National basic fee paid | 08.05.2018 | Search fee paid | 08.05.2018 | Designation fee(s) paid | 08.05.2018 | Examination fee paid | Examination procedure | 08.05.2018 | Examination requested [2018/33] | 08.05.2018 | Date on which the examining division has become responsible | 21.11.2019 | Amendment by applicant (claims and/or description) | 24.06.2020 | Despatch of a communication from the examining division (Time limit: M06) | 04.01.2021 | Reply to a communication from the examining division | 12.01.2022 | Despatch of a communication from the examining division (Time limit: M06) | 21.07.2022 | Reply to a communication from the examining division | 01.05.2024 | Application deemed to be withdrawn, date of legal effect [2024/38] | 24.05.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/38] | Fees paid | Renewal fee | 08.05.2018 | Renewal fee patent year 03 | 25.10.2019 | Renewal fee patent year 04 | 30.10.2020 | Renewal fee patent year 05 | 25.10.2021 | Renewal fee patent year 06 | 25.10.2022 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.10.2023 | 08   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO02095417 (UNIV DUNDEE [GB], et al) [X] 1,6,8 * the whole document * [I] 2,7; | [X] - A. KLEINRIDDERS ET AL., "PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis", MOLECULAR AND CELLULAR BIOLOGY, (20090601), vol. 29, no. 11, doi:10.1128/MCB.01807-08, ISSN 0270-7306, pages 3173 - 3185, XP055373922 [X] 9 * the whole document * DOI: http://dx.doi.org/10.1128/MCB.01807-08 | International search | [XA]CN1328026 (BODE GENE DEV CO LTD SHANGHAI [CN]) [X] 1-3, 6-7, 9-13 * See instructions 2-3, 14, 16-18. * [A] 4-5; | [XA]CN1333240 (BODE GENE DEV CO LTD SHANGHAI [CN]) [X] 1-3, 6-7, 9-13 * See instructions 2-3, 14, 16-8. * [A] 4-5; | [A]US2004253646 (LAMOND ANGUS IAIN [GB], et al) [A] 1-7, 9-13 * See claims 1-26. *; | [A]KR20100018237 (KOREA INST SCI & TECH [KR]) [A] 1-7, 9-13* See claims 1, 4-6. *; | [A] - KLEINRIDDERS, A. et al., "PLRG1 Is an Essential Regulator of Cell Proliferation and Apoptosis during Vertebrate Development and Tissue Homeostasis", Molecular and Cellular Biology, (20090000), vol. 29, no. 11, pages 3173 - 3185, XP055373922 [A] 1-7, 9-13 * , See page 3173. * DOI: http://dx.doi.org/10.1128/MCB.01807-08 |